Acknowledgement
Supported by : Korea Science and Engineering Foundation, Yeungnam University
References
- Barter, P.J., Nicholls, S., Rye, K.A., Anantharamaiah, G.M., Naval, M., and Fogelman, A.M. (2004). Antiinflammatory properties of HDL. Circ. Res. 9, 764-772 https://doi.org/10.1161/01.RES.0000146094.59640.13
- Breyer, E.D., Le, N.A., Li, X., Martinson, D., and Brown, W.V. (1999). Apolipoprotein C-III displacement of apolipoprotein E from VLDL:effect of particle size. J. Lipid Res. 40, 1875-1882
- Brousseau, M.E. (2005). Emerging role of high-density lipoprotein in the prevention of cardiovascular disease. Drug Discov. Today 10, 1095-1101 https://doi.org/10.1016/S1359-6446(05)03514-2
- Brown, M.L., Inazu, A., Hesler, C.B., Agellon, L.B., Mann, C., Whitlock, M.E., Marcel, Y.L., Milne, R.W., Koizumi, J., Mabuchi, H., et al. (1989). Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 342, 448-51 https://doi.org/10.1038/342448a0
- Bruns, G.A., Karathanasis, S.K., and Breslow, J.L. (1984). Human apolipoprotein A-I--C-III gene complex is located on chromosome 11. Arteriosclerosis 4, 97-102 https://doi.org/10.1161/01.ATV.4.2.97
- Cho, K.H., and Jonas, A. (2000). A key point mutation (V156E) affects the structure and functions of human apolipoprotein A-I. J. Biol. ChemK 275, 26821-26827 https://doi.org/10.1074/jbc.M002841200
- Cho, K.H., Lee, J.Y., Choi, M.S., Cho, J.M., Lim, J.S., and Park, Y.B.(1998). A peptide from hog plasma that inhibits human cholesteryl ester transfer protein. Biochim. Biophys. Acta 30, 133-144 https://doi.org/10.1016/S0005-2760(97)00197-5
- Cho, K.H., Shin, D.G., Baek, S.H., and Kim, J.R. (2009). Myocardial infarction patients showed altered lipoprotein properties and functions when compared with stable angina pectoris patients. Exp. Mol. Med. 41, 67-76 https://doi.org/10.3858/emm.2009.41.2.009
- Ginsberg, H.N., Le, N.A., Goldberg, I.J., Gibson, J.C., Rubinstein, A., Wang-Iverson, P., Norum, R., and Brown, W.V. (1986). Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J. Clin. Invest. 78, 1287-1295 https://doi.org/10.1172/JCI112713
- Ginsberg, H.N., Jones, J., Blaner, W.S., Thomas, A., Karmally, W., Fields, L., Blood, D., and Begg, M.D. (1995). Association of postprandial triglyceride and retinyl plalmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women. Arterioscler. Thromb. Vasc. Biol. 15, 1829-1838 https://doi.org/10.1161/01.ATV.15.11.1829
- Han, J.M., Jeong, T.S., Lee, W.S., Choi, I., and Cho, K.H. (2005). Structural and functional properties of V156K and A158E mutants of apolipoprotein A-I in the lipid-free and lipid-bound states. J. Lipid. Res. 46, 589-596 https://doi.org/10.1194/jlr.M400468-JLR200
- Hodis, H.N. (1999). Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis. Circulation 99, 2852-2854 https://doi.org/10.1161/01.CIR.99.22.2852
- Jonas, A. (1991). Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins. Biochim. Biophys. Acta 1084, 205-220 https://doi.org/10.1016/0005-2760(91)90062-M
- Jonas, A., Sweeny, S.A., and Herber, P.N. (1984). Discoidal complexes of A and C apolipoproteins with lipids and their reactions with lecithin:cholesterol acyltransferase. J. Biol. Chem. 259, 6369-6375
- Jonas, A., Kezdy, K.E., and Wald, J.H. (1989). Defined apolipoprotein A-I conformations in reconstituted high density lipoprotein discs. J. Biol. Chem. 264, 4818-4824
- Jonas, A., Wald, J.H., Toohill, K.L., Krul, E.S., and Kezdy, K.E. (1990). Apolipoprotein A-I structure and lipid properties in homogeneous, reconstituted spherical and discoidal high density lipoproteins. J. Biol. Chem. 265, 22123-22129
- Lee, S., Campos, H., Moye, L.A., and Sacks, F.M. (2003). LDL containing apolipoprotein C-III is an independent risk factor for coronary events in diabetic patients. Arterioscler. Thromb. Vasc. Biol. 23, 853-858 https://doi.org/10.1161/01.ATV.0000066131.01313.EB
- Lewis, G.F., and Rader, D.J. (2005). New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res. 96, 1221-1232 https://doi.org/10.1161/01.RES.0000170946.56981.5c
- Markwell, M.A., Haas, S.M., Bieber, L.L., and Tolbert, N.E. (1978). A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. BiochemK 87, 206-210 https://doi.org/10.1016/0003-2697(78)90586-9
- Matz, C.E., and Jonas, A. (1982). Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem 257, 4535-4540
- Nishida, H.I., Nakanishi, T., Yen, E.A., Arai, H., Yen, F.T., and Nishida, T. (1986). Nature of the enhancement of lecithincholesterol acyltransferase reaction by various apolipoproteins. J. Biol. Chem. 261, 12028-12035
- Onat, A., Hergenc, G., Sansoy, V., Fobker, M., Ceyhan, K., Toprak, S., and Assmann, G. (2003). Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders. Atherosclerosis 168, 81-89 https://doi.org/10.1016/S0021-9150(03)00025-X
- Ooi, E.M.M., Barrett, P.H.R., Chan, D.C., and Watts, G.F. (2008). Apolipoprotein C-III:understanding an emerging cardiovascular risk factor. Clin. Sci. 114, 611-624 https://doi.org/10.1042/CS20070308
- Park, S.H., Park, J.E., Kim, Y.O., Song, K.J., Kim, S.S., Kim, J.R., Choi, I., Kim, J.J., and Cho, K.H. (2008). Function and composition of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients. Clin. Biochem. 41, 56-64 https://doi.org/10.1016/j.clinbiochem.2007.10.007
- Pownall, H.J., Massey, J.B., Kusserow, S.K., and Gotto, A.M., Jr. (1978). Kinetics of lipid-protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines. Biochemistry 17, 1183-1188 https://doi.org/10.1021/bi00600a008
- Sacks, F.M., Alaupovic, P., Moye, L.A., Cole, T.G., Sussex, B., Stampfer, M.J., Pfeffer, M.A., and Braunwald, E. (2000). VLDL, Apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the cholesterol and recurrent events (CARE). Trial. Circulation 102, 1886-1892 https://doi.org/10.1161/01.CIR.102.16.1886
- Shachter, N.S. (2001). Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr. Opin. Lipidol. 12, 297-304 https://doi.org/10.1097/00041433-200106000-00009
- Sparks, D.L., and Pritchard, P.H. (1989). Transfer of cholesteryl ester into high density lipoprotein by cholesteryl ester transfer protein: effect of HDL lipid and apoprotein content. J. Lipid. Res. 30, 1491-1498
- Staros, J.V. (1982). N-hydroxysulfosuccinimide active esters: bis Nhydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers. Biochemistry 21, 3950-3955 https://doi.org/10.1021/bi00260a008
- Ting, H.J., Stice, J.P., Schaff, U.Y., Hui, D.Y., Rutledge, J.C., Knowlton, A.A., Passerini, A.G., and Simon, S.I. (2007). Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha. Circ. Res. 100, 381-390 https://doi.org/10.1161/01.RES.0000258023.76515.a3
- Wang, C.S., McConathy, W.J., Kloer, H.U., and Alaupovic, P. (1985). Modulation of lipoprotein lipase activity by apolipoproteins. J. Clin. Invest. 75, 384-390 https://doi.org/10.1172/JCI111711
Cited by
- Biomedicinal implications of high-density lipoprotein: its composition, structure, functions, and clinical applications vol.42, pp.7, 2009, https://doi.org/10.5483/bmbrep.2009.42.7.393
- Inhibition of collar-induced carotid atherosclerosis by recombinant apoA-I cysteine mutants in apoE-deficient mice vol.51, pp.12, 2010, https://doi.org/10.1194/jlr.m008573
- Severely modified lipoprotein properties without a change in cholesteryl ester transfer protein activity in patients with acute renal failure secondary to Hantaan virus infection vol.43, pp.8, 2009, https://doi.org/10.5483/bmbrep.2010.43.8.535
- Effect in vitro of apolipoprotein A-V on the structure and functions of recombinant high density lipoprotein vol.401, pp.3, 2009, https://doi.org/10.1016/j.bbrc.2010.09.084
- Modified apolipoprotein (apo) A-I by artificial sweetener causes severe premature cellular senescence and atherosclerosis with impairment of functional and structural properties of apoA-I in lipid-fre vol.31, pp.5, 2011, https://doi.org/10.1007/s10059-011-1009-3
- Enhanced Delivery of Rapamycin by V156K-apoA-I High-Density Lipoprotein Inhibits Cellular Proatherogenic Effects and Senescence and Promotes Tissue Regeneration vol.66, pp.12, 2011, https://doi.org/10.1093/gerona/glr169
- Turmeric and Laurel Aqueous Extracts Exhibit In Vitro Anti-Atherosclerotic Activity and In Vivo Hypolipidemic Effects in a Zebrafish Model vol.14, pp.3, 2009, https://doi.org/10.1089/jmf.2009.1389
- Water extracts of cinnamon and clove exhibits potent inhibition of protein glycation and anti-atherosclerotic activity in vitro and in vivo hypolipidemic activity in zebrafish vol.49, pp.7, 2011, https://doi.org/10.1016/j.fct.2011.03.043
- A zebrafish model for the rapid evaluation of pro-oxidative and inflammatory death by lipopolysaccharide, oxidized low-density lipoproteins, and glycated high-density lipoproteins vol.31, pp.6, 2009, https://doi.org/10.1016/j.fsi.2011.08.006
- A proteoliposome containing apolipoprotein A-I mutant (V156K) enhances rapid tumor regression activity of human origin oncolytic adenovirus in tumor-bearing zebrafish and mice vol.34, pp.2, 2009, https://doi.org/10.1007/s10059-012-2291-4
- Females with angina pectoris have altered lipoprotein metabolism with elevated cholesteryl ester transfer protein activity and impaired high-density lipoproteins-associated antioxidant enzymes vol.29, pp.4, 2009, https://doi.org/10.3892/ijmm.2011.874
- Grape skin and loquat leaf extracts and acai puree have potent anti-atherosclerotic and anti-diabetic activity in vitro and in vivo in hypercholesterolemic zebrafish vol.30, pp.3, 2009, https://doi.org/10.3892/ijmm.2012.1045
- Association Between Lipids, Lipoproteins Composition of HDL Particles and Triglyceride-Rich Lipoproteins, and LCAT and CETP Activity in Post-renal Transplant Patients vol.67, pp.2, 2009, https://doi.org/10.1007/s12013-013-9559-y
- Bovine apolipoprotein (apo)A-I displays more enhanced antioxidant and anti-atherosclerotic activity in lipid-free and lipid-bound states than human and porcine apoA-I vol.32, pp.4, 2009, https://doi.org/10.3892/ijmm.2013.1473
- Evolving targets for lipid-modifying therapy vol.6, pp.10, 2014, https://doi.org/10.15252/emmm.201404000
- Incorporation of Human Growth Hormone-2 into Proteoliposome Enhances Tissue Regeneration with Anti-Oxidant and Anti-Senescence Activities vol.18, pp.1, 2009, https://doi.org/10.1089/rej.2014.1594
- Reconstituted High-Density Lipoprotein Containing Human Growth Hormone-1 Shows Potent Tissue Regeneration Activity with Enhancement of Anti-Oxidant and Anti-Atherosclerotic Activities vol.18, pp.3, 2015, https://doi.org/10.1089/rej.2014.1644
- Enhancement of High-Density Lipoprotein Cholesterol Functions by Encapsulation of Policosanol Exerts Anti-Senescence and Tissue Regeneration Effects Via Improvement of Anti-Glycation, Anti-Apoptosis, vol.19, pp.1, 2016, https://doi.org/10.1089/rej.2015.1712
- Anti-Aging and Tissue Regeneration Ability of Policosanol Along with Lipid-Lowering Effect in Hyperlipidemic Zebrafish via Enhancement of High-Density Lipoprotein Functionality vol.19, pp.2, 2016, https://doi.org/10.1089/rej.2015.1745
- Development of Antisense Drugs for Dyslipidemia vol.23, pp.9, 2009, https://doi.org/10.5551/jat.rv16001
- Apolipoprotein C-III Nanodiscs Studied by Site-Specific Tryptophan Fluorescence vol.55, pp.35, 2009, https://doi.org/10.1021/acs.biochem.6b00599
- Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process vol.11, pp.10, 2009, https://doi.org/10.1371/journal.pone.0164564
- Altered lipoproteins in patients with systemic lupus erythematosus are associated with augmented oxidative stress: a potential role in atherosclerosis vol.18, pp.None, 2009, https://doi.org/10.1186/s13075-016-1204-x
- Impaired Antioxidant Ability of HDL and More Oxidized LDL are associated with Male Patients with Atrial Fibrillation vol.5, pp.2, 2016, https://doi.org/10.12997/jla.2016.5.2.145
- Consumption of policosanol enhances HDL functionality via CETP inhibition and reduces blood pressure and visceral fat in young and middle-aged subjects vol.39, pp.4, 2009, https://doi.org/10.3892/ijmm.2017.2907
- The Ability of Different Ketohexoses to Alter Apo-A-I Structure and Function In Vitro and to Induce Hepatosteatosis, Oxidative Stress, and Impaired Plasma Lipid Profile in Hyperlipidemic Zebrafish vol.2018, pp.None, 2009, https://doi.org/10.1155/2018/3124364
- Consumption of Cuban Policosanol Improves Blood Pressure and Lipid Profile via Enhancement of HDL Functionality in Healthy Women Subjects: Randomized, Double-Blinded, and Placebo-Controlled Study vol.2018, pp.None, 2009, https://doi.org/10.1155/2018/4809525
- Slim Body Weight Is Highly Associated With Enhanced Lipoprotein Functionality, Higher HDL-C, and Large HDL Particle Size in Young Women vol.9, pp.None, 2009, https://doi.org/10.3389/fendo.2018.00406
- Blood Pressure Lowering Effect of Cuban Policosanol is Accompanied by Improvement of Hepatic Inflammation, Lipoprotein Profile, and HDL Quality in Spontaneously Hypertensive Rats vol.23, pp.5, 2009, https://doi.org/10.3390/molecules23051080
- Cuban Sugar Cane Wax Acid and Policosanol Showed Similar Atheroprotective Effects with Inhibition of LDL Oxidation and Cholesteryl Ester Transfer via Enhancement of High-Density Lipoproteins Functiona vol.2019, pp.None, 2009, https://doi.org/10.1155/2019/8496409
- Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease vol.18, pp.1, 2009, https://doi.org/10.1186/s12944-019-1166-5
- Structural and Functional Impairments of Reconstituted High-Density Lipoprotein by Incorporation of Recombinant β-Amyloid42 vol.26, pp.14, 2009, https://doi.org/10.3390/molecules26144317